AP
Anand Pahadi Nishad
About Anand Pahadi Nishad
Data last updated:
Anand Pahadi Nishad is a Director at Canvass Clinical Research Services Private Limited (since 2024) and Director at Schwandt Ujagare Alternative Medicine Private Limited (since 2023). The companies operate in Pharma and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹1.05 Cr; the largest is Canvass Clinical Research Services Private Limited at ₹93.2 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Canvass Clinical Research Services Private Limited U73100MH2019PTC321831 | Director | 26 Jun 2024 | 2019 | ₹93.2 Lakh (FY 2024) | Active |
 Schwandt Ujagare Alternative Medicine Private Limited U74999MH2017PTC294103 | Director | 18 Mar 2023 | 2017 | ₹11.9 Lakh (FY 2025) | Active |
Board colleagues of Anand Pahadi Nishad
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mangal Tanajirao Bhakte | 09116690 | Canvass Clinical Research Services Private Limited | Director |
| Vijaya Tanajirao Bhakte | 08374165 | Canvass Clinical Research Services Private Limited | Director |
| Olga Viktorowna Schwandt | 07738754 | Schwandt Ujagare Alternative Medicine Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anand Pahadi Nishad
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anand Pahadi Nishad
Anand Pahadi Nishad currently holds 2 directorships: Canvass Clinical Research Services Private Limited (Director, since 26 Jun 2024, revenue ₹93.2 Lakh (FY 2024)); Schwandt Ujagare Alternative Medicine Private Limited (Director, since 18 Mar 2023, revenue ₹11.9 Lakh (FY 2025)).
Anand Pahadi Nishad was first appointed on 18 Mar 2023 as Director at Schwandt Ujagare Alternative Medicine Private Limited. The most recent appointment on record is 26 Jun 2024 at Canvass Clinical Research Services Private Limited.
The 2 current companies of Anand Pahadi Nishad that report revenue have a combined latest revenue of ₹1.05 Cr: Canvass Clinical Research Services Private Limited ₹93.2 Lakh (FY 2024); Schwandt Ujagare Alternative Medicine Private Limited ₹11.9 Lakh (FY 2025).
The current boards of Anand Pahadi Nishad's companies include Mangal Tanajirao Bhakte (Canvass Clinical Research Services Private Limited), Vijaya Tanajirao Bhakte (Canvass Clinical Research Services Private Limited), Olga Viktorowna Schwandt (Schwandt Ujagare Alternative Medicine Private Limited).